Since ancient times, people have been using therapeutic herbs; in fact, this practice might have been the forerunner of modern medicine.
It has been noted that the focus of worldwide research is shifting away from the cultivation or domestication of plant species and toward
the discovery of novel medications or active chemicals. Because contemporary synthetic medication is unavailable to the developing
world, traditional medicine based on the direct application of medicinal plants is still practiced in many parts of the world due to its low cost.
Bulbophyllum is the largest genus of the family Orchidaceae. Bulbophyllum crassipes Hook.f. is one of the most important epiphytic orchid
species amongst the 2199 species (POWO, 2025) of the genus Bulbophyllum. It has the special characters of single noded pseudobulb
and basal inflorescence. Since ancient times, Bulbophyllum orchids have occupied a distinct place in human’s life for treatment of a variety
of ailments. Owing to insufficient data of this species on the medicinal aspect, there is an immediate need to carry out research on this
particular area. In the present communication, pharmacognostic study such as organoleptic characters, macroscopic study, microscopic
study, physicochemical analysis, phytochemical screening, and in vitro anti-oxidant, and anti-inflammatoy activity of B. crassipes are
reported. The IC50 values for in-vitro anti-oxidant activity were reported to be 193.92, 192.12, 204.43, 406.86, 515.52 μgml-1, and 34.01 μgml-
1 for different extracts (hydroalcohol, methanol, ethyl acetate, petroleum ether, and ascorbic acid, respectively). For anti-inflammatoy
activity the IC50 of hydroalcohol, methanol, ethyl acetate, and petroleum ether extracts were found as 695.09, 689.65, 728.06, 831.60,854.75
μgml-1 respectively, where the IC50 of diclofeinac sodium was observed as 167.30 μgml-1.